Scheduling action

A scheduling action is a formal decision by a legislative body, administrative agency, or treaty organ placing a substance under legal control—or moving it between tiers of an existing framework. The decision creates a legal object: a position within a controlled-substances system, with defined consequences for possession, supply, prescribing, and research.

The term is procedural. A "schedule" is the list; a scheduling action is the act of placing something on it, reclassifying it, or removing it. On substance pages, the tier a compound currently holds is the outcome of one or more past scheduling actions, which may have been temporary, contested, or reversed.

What it means in practice

How a substance enters control varies by system. In the United States, the Drug Enforcement Administration can invoke emergency scheduling to place a substance under temporary control without completing a full scientific review; permanent placement follows a longer process concluded by a rule in the Federal Register.

Under the UN treaty system, the WHO's Expert Committee on Drug Dependence reviews candidates and issues recommendations; the Commission on Narcotic Drugs then votes on final placement. Member states are treaty-bound to enact domestic controls, though each determines the precise mechanism.

Analogue provisions in some frameworks extend a scheduling action's reach to structurally similar compounds. These provisions are worded narrowly enough that successive structural variants have repeatedly appeared outside their scope—a pattern the literature records as a near-constant feature of the regulatory cycle.

How jurisdictions vary

Schedule numbers do not travel between legal systems. In the United States, Schedule I is the most restrictive domestic tier, carrying the statutory finding of "no currently accepted medical use"—a legal phrase with a defined regulatory meaning, not a summary of the clinical literature. The same number means something different elsewhere.

The United Kingdom organises criminality under the Misuse of Drugs Act 1971 by Class (A, B, or C), not numbered schedules. A separate set of numbered schedules within the same Act governs medical possession—a parallel system that regularly confuses readers encountering UK drug law for the first time.

Australia's Poisons Standard uses schedules numbered 1 through 10, with Schedule 9 covering prohibited substances—running in the opposite direction from US intuition. At the treaty level, the 1971 Convention on Psychotropic Substances uses four schedules with tier boundaries distinct from any national counterpart.

What is contested

Several substances classified at Schedule I in the United States—a tier carrying the statutory finding of no currently accepted medical use—have also received FDA breakthrough therapy designations for specific clinical indications, a status granted when preliminary evidence suggests a drug may offer substantial improvement over existing treatments. Psilocybin and MDMA are among those in this position.

The two determinations can coexist because "currently accepted medical use" is a statutory phrase with a defined regulatory meaning, not a direct readout of the trial literature. Psychedex records both facts side by side.

Scope and currency

This entry describes the concept of a scheduling action as a general legal instrument. It is not legal advice and does not describe the law in any reader's jurisdiction. Scheduling status differs between countries, between federal and sub-national levels within a country, and over time as new actions are taken.

Per-substance legal status sections carry the jurisdiction, date, and source needed for any specific question. This entry states the position as of August 2026.